Purchase Order HU000124P0035
Award Date
5/17/24
Potential Completion Date
11/17/24
Potential Value
$1.1M
Federal Agency
Uniformed Services University of the Health Sciences
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the Department of the Navy's Naval Supply Systems Command to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The contract, valued at $135,878.00, is for the provision of a NovaSeq sequencing system, related consumables, and a 0.25 maintenance plan. The contract has a completion date of January 12, 2025 and was awarded on December 28, 2023. This award does not appear to be associated with a larger...
This is a firm fixed-price purchase order worth $499,633.76 awarded by the Defense Health Agency to Illumina, Inc. for the procurement of a NEXTSEQ 550 SEQUENCING SYSTEM. The contract has no set-aside designation. Illumina has been a long-standing provider of sequencing instruments, reagents, and bioinformatics solutions to various federal agencies, including the NIH, CDC, USDA, and VA, to support genomic research and diagnostics. While this appears to be a standalone purchase order, Illumina...
This is a $125,814.00 firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Illumina, Inc. The contract is for NovaSeq Silver Support services, which includes the provision of sequencing systems, reagents, and maintenance services to support genomic sequencing and analysis. Illumina is the sole manufacturer of the NovaSeq and related instruments used under this order. The contract has no set-aside designation and is not associated with a larger...
This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The $249,894.20 contract is for the delivery of an Illumina MiSeq sequencing system, to be used at the agency's location in Rockville, Maryland. Illumina has provided similar sequencing systems and related supplies to support genomic research and diagnostics at various federal agencies, including...
This firm fixed price purchase order was awarded by the Defense Health Agency to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $630,846 contract is for the provision of a NEXTSEQ 550DX SEQUENCING SYSTEM, with a completion date of November 30, 2018. Illumina has a history of providing a range of sequencing equipment and supplies to federal agencies like the NIH, CDC, USDA, and VA for research and diagnostic purposes. Additionally, Illumina holds an...
This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $15,807.96 award provides Illumina's proprietary sequencing systems, reagents, and services to support nucleic acid sequencing needs, with no set-aside designation. The order is part of a larger Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery, valued up...
The U.S. Department of Defense Uniformed Services University of the Health Sciences awarded Illumina, Inc., a for-profit manufacturer, a $2,909,936.25 firm fixed-price purchase order for three NovaSeq 6000 genomic sequencing systems. The sole-source award supports precision medicine research and was made under FAR Part 12 Commercial Items and FAR Part 13.5 Simplified Procedures. Illumina was selected as the sole provider due to its proprietary technology and leadership in genome sequencing....
This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
This is a $249,998.65 firm fixed price delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic and genomic analysis instruments and reagents. The order is for NovaSeq X Series sequencing reagent kits and freight, with a period of performance through September 2025. This order is part of a broader indefinite delivery contract Illumina holds with the Department of the...
This is a $48,647 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer and provider of genomic sequencing and analysis solutions. The contract is for the purchase of Illumina's genetic sequencing products, including NextSeq, NovaSeq, MiSeq, and iSeq systems, as well as accompanying reagents, consumables, and support services. This award is part of a larger Indefinite Delivery Contract worth up to $3.3 million that...